title: Serological follow-up of patients involved in a localized outbreak of leptospirosis.
abstract: Eighteen patients involved in a localized outbreak of leptospirosis were subjected to a serological follow-up study over a 5-year period. Four distinct sets of sera from all patients and a fifth sample obtained from 10 of them were examined by the microscopic agglutination test (MAT) for demonstration of leptospiral antibodies. The test was carried out by using live leptospires from reference strains of 17 Leptospira interrogans serovars known to occur in Italy. In all cases, the highest titers of agglutinins were recorded against one or more of the three Australis group serovars tested (australis, bratislava, and lora). The highest antibody levels were reached soon after the acute phase of infection in some patients but only after some months in others. Titers then tended to recede with varying rapidity, but titers against the Australis group serovars were still detectable in some patients after 5 years. Coagglutinins against serovars of other serogroups were detected, generally at low levels, in the early sets of sera of most patients, but tended to disappear in the late-set sera. Specific immunoglobulin M (IgM) and IgG against the three Australis group serovars were determined in most serum samples from 16 patients by solid-phase enzyme immunoassay (EIA). In general, EIA titers were considerably lower than MAT titers, but there was a certain patient-to-patient variability in both the IgM/IgG ratio and the evolution and persistence of the two immunoglobulin classes. Since all the evidence indicated that the initial outbreak from a single source, the observed patient-to-patient variability in the progress of both MAT and EIA titers appeared to be attributable to factors inherent in the individual patients. Cross agglutination absorption tests, aimed at retrospectively determining to which of the Australis group serovars the outbreak-specific infecting strain belonged, were performed with six serum samples from different patients. Most absorbed sera seemed to originate from an australis or lora infection, but it was not possible to discriminate conclusively between the two serovars.
authors.affiliation: Institute of Microbiology, University of Ancona Medical School, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Lupidi
authors.forename: M
authors.initials: M
authors.lastname: Cinco
authors.forename: D
authors.initials: D
authors.lastname: Balanzin
authors.forename: E
authors.initials: E
authors.lastname: Delprete
authors.forename: P E
authors.initials: PE
authors.lastname: Varaldo
mesh_terms: D000328:Adult; D000368:Aged; D000372:Agglutination Tests; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D004196:Disease Outbreaks; D004326:Drinking; D005260:Female; D005500:Follow-Up Studies; D006364:Hedgehogs; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D007558:Italy / Q000453:epidemiology; D007921:Leptospira interrogans / Q000276:immunology / Q000302:isolation & purification*; D008297:Male; D008875:Middle Aged; D014871:Water Microbiology; D014895:Weil Disease / Q000453:epidemiology*
chemical_list: D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007075:Immunoglobulin M